Navigation Links
Summits on translational science bridge domains critical to health advancements

San Francisco, March 7, 2011 A ground-breaking pair of scientific meetings, the Joint Summits on Translational Science, open today with several hundred scientists, researchers, academic leaders, and nonprofit and corporate leaders in biomedicine who share a common interest in transforming biomedical research discoveries into clinical treatments and health promotion. AMIA, the association for informatics professionals, convenes the week-long Joint Summits on Translational Bioinformatics (TBI) and Clinical Research Informatics (CRI) to meet the knowledge-driven needs of translational scientists who use the Summits as a key venue in which to share the spectrum of their work in discovery-driven science from 'bench to bedside', find collaborative partners, and network with peers also interested in bridging innovation in biomedical research to patient care.

"AMIA's commitment to TBI and CRI is fundamental to its mission of bridging knowledge and collaboration across a continuum, from basic and applied research to public health and consumer areas," says Edward H. Shortliffe, MD, PhD, FACMI, president and CEO of AMIA. "The Joint Summits provide a unique opportunity for researchers in translational science to come together in a single venue, and to span the full range of informatics applications from basic human biology to clinical care."

"This meeting provides a unique opportunity to bring together the finest minds in TBI and CRI," says TBI Summit Chair Indra Neil Sarkar, PhD, MLIS, director of biomedical informatics and assistant professor at the University of Vermont's Center for Clinical and Translational Science. "The TBI Summit, now in its fourth year, has embraced the trans-disciplinary nature of translational bioinformatics to become the foremost forum for scientific pioneers in biology and health care."

TBI content at the Summit is broken down into four tracks: informatics concepts, tools and techniques to enable integrative translational bioinformatics research; informatics methods for the integrative analysis of molecular and clinical measurements; relating and representing phenotypes and disease for translational bioinformatics research; and informatics methods bridging basic science discoveries and clinical practice.

Keynote presentations feature Kenneth H. Buetow, PhD, director of the National Cancer Institute's Center for Bioinformatics and Information Technology; Carl Zimmer, lecturer at Yale University, journalist and author; and Lincoln Stein, MD, PhD, platform leader of Informatics and Bio-computing at Ontario Institute for Cancer Research. Collectively, these individuals exemplify contributions that translational scientists make in the health sector; analysis and presentation of scientific findings in the context of the role of genetics in complex human diseases such as cancer; and the application of sophisticated informatics technologies to solve major biomedical challenges.

CRI Summit Chair Philip R.O. Payne, PhD, chair of the Department of Biomedical Informatics at The Ohio State University explains, "The CRI Summit provides an unparalleled opportunity for individuals and organizations at all levels to develop and enhance a comprehensive understanding of the CRI landscape. Bringing TBI and CRI professionals together accelerates work at their intersecting areas of focus and introduces added value to both fields--an even greater benefit to the larger healthcare community."

CRI content at the Summit is broken down into multiple tracks: Research Planning and Participant Recruitment; Data Management, Sharing and Representation; People, Organizational, and Policy Issues; and Educational and Community Development. More information about the program sessions, the keynote speakers and attendees is online at

The AMIA Joint Summits will feature up-to-date coverage on Twitter @AMIAInformatix and #TBICRI11.


Contact: Nancy Light
American Medical Informatics Association

Related biology news :

1. 3 new informatics pilot projects to aid clinical and translational scientists nationwide
2. NIH Clinical and Translational Science Consortium grows to 39 members
3. Faculty of Translational Medicine boosts support for biomedical researchers
4. Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues
5. IRSF announces translational research award funding to test potential therapeutics for Rett syndrome
6. Science Translational Medicine adds 12 new associate scientific advisors
7. Covance Establishes New Discovery & Translational Services Group
8. Covance Establishes New Discovery & Translational Services Group
9. National Eye Institute hosts Translational Research and Vision Symposium
10. USC wins $56.8M NIH award for clinical and translational research
11. Strategies for translational research in the UK
Post Your Comments:
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( ) will also ... by the use of DNA technology to an industry ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... ... the launch of the Supplyframe Design Lab . Located in Pasadena, Calif., ... the future of how hardware projects are designed, built and brought to market. ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... 23, 2016 On Wednesday, June 22, ... down 0.22%; the Dow Jones Industrial Average edged 0.27% lower ... 2,085.45, down 0.17%. has initiated coverage on the following ... Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
Breaking Biology Technology: